Publication

Cardiac Substructure Radiation Dose and Risk of Late Cardiac Disease in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study

Downloadable Content

Persistent URL
Last modified
  • 07/07/2026
Type of Material
Authors
    James E. Bates, Emory UniversitySuman Shrestha, MD Anderson Cancer CenterQi Liu, University of AlbertaSusan A. Smith, MD Anderson Cancer CenterDaniel A. Mulrooney, St. Jude Children's Research HospitalWendy Leisenring, Fred Hutchinson Cancer Research CenterTodd Gibson, National Cancer InstituteLeslie L. Robison, St. Jude Children’s Research HospitalEric J. Chow, Fred Hutchinson Cancer Research CenterKevin C. Oeffinger, Duke UniversityGregory t. Armstrong, St. Jude Children’s Research HospitalLouis S. Constine, University of RochesterBradford S. Hoppe, Mayo Clinic, JacksonvilleChoonsik Lee, National Cancer InstituteYutaka Yasui, St. Jude Children’s Research HospitalRebecca M. Howell, MD Anderson Cancer Center
Language
  • English
Date
  • 2023-06-12
Publisher
  • American Society of Clinical Oncology
Publication Version
Copyright Statement
  • © 2023 by American Society of Clinical Oncology
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 41
Issue
  • 22
Start Page
  • 3826
End Page
  • 3838
Grant/Funding Agency
  • National Cancer Institute
  • American Lebanese-Syrian Associated Charities
  • Cancer Center Sup
Grant/Funding Information
  • Supported by the National Cancer Institute (CA55727, G.T.A.; R01-CA261750, R.M.H., Y.Y., D.A.M., J.E.B.; R01-216354, Y.Y.). Support to St Jude Children's Research Hospital also provided by the Cancer Center Support (CORE) grant (CA21765) and the American Lebanese-Syrian Associated Charities.
Abstract
  • PURPOSE Radiation-associated cardiac disease is a major cause of morbidity/mortality among childhood cancer survivors. Radiation dose-response relationships for cardiac substructures and cardiac diseases remain unestablished. METHODS Using the 25,481 5-year survivors of childhood cancer treated from 1970 to 1999 in the Childhood Cancer Survivor Study, we evaluated coronary artery disease (CAD), heart failure (HF), valvular disease (VD), and arrhythmia. We reconstructed radiation doses for each survivor to the coronary arteries, chambers, valves, and whole heart. Excess relative rate (ERR) models and piecewise exponential models evaluated dose-response relationships. RESULTS The cumulative incidence 35 years from diagnosis was 3.9% (95% CI, 3.4 to 4.3) for CAD, 3.8% (95% CI, 3.4 to 4.2) for HF, 1.2% (95% CI, 1.0 to 1.5) for VD, and 1.4% (95% CI, 1.1 to 1.6) for arrhythmia. A total of 12,288 survivors (48.2%) were exposed to radiotherapy. Quadratic ERR models improved fit compared with linear ERR models for the dose-response relationship between mean whole heart and CAD, HF, and arrhythmia, suggesting a potential threshold dose; however, such departure from linearity was not observed for most cardiac substructure end point dose-response relationships. Mean doses of 5-9.9 Gy to the whole heart did not increase the risk of any cardiac diseases. Mean doses of 5-9.9 Gy to the right coronary artery (rate ratio [RR], 2.6 [95% CI, 1.6 to 4.1]) and left ventricle (RR, 2.2 [95% CI, 1.3 to 3.7]) increased risk of CAD, and to the tricuspid valve (RR, 5.5 [95% CI, 2.0 to 15.1]) and right ventricle (RR, 8.4 [95% CI, 3.7 to 19.0]) increased risk of VD. CONCLUSION Among children with cancer, there may be no threshold dose below which radiation to the cardiac substructures does not increase the risk of cardiac diseases. This emphasizes their importance in modern treatment planning.
Author Notes
  • Competing interests: James E. Bates Employment: Emory University Stock and Other Ownership Interests: Doximity Consulting or Advisory Role: Galera Therapeutics, Castle Biosciences Daniel A. Mulrooney This author is a member of the Journal of Clinical Oncology Editorial Board. Journal policy recused the author from having any role in the peer review of this manuscript. Eric J. Chow Research Funding: Abbott Gregory T. Armstrong Honoraria: Grail Louis S. Constine Honoraria: UpToDate, Springer, Lippincott Bradford S. Hoppe Consulting or Advisory Role: Merck (Inst) Rebecca M. Howell Research Funding: MD Anderson Cancer Center No other potential conflicts of interest were reported.
  • Correspondence: James E. Bates, MD, Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30308; Twitter: @JamesBatesMD; e-mail: james.edward.bates@emory.edu.
  • Author contributions: Conception and design: James E. Bates, Wendy Leisenring, Leslie L. Robison, Kevin C. Oeffinger, Gregory T. Armstrong, Louis S. Constine, Bradford S. Hoppe, Rebecca M. Howell Financial support: Gregory T. Armstrong, Rebecca M. Howell Administrative support: Gregory T. Armstrong Provision of study materials or patients: Leslie L. Robison, Gregory T. Armstrong Collection and assembly of data: James E. Bates, Suman Shrestha, Susan A. Smith, Wendy Leisenring, Leslie L. Robison, Eric J. Chow, Gregory T. Armstrong, Bradford S. Hoppe, Choonsik Lee, Rebecca M. Howell Data analysis and interpretation: James E. Bates, Suman Shrestha, Qi Liu, Daniel A. Mulrooney, Todd Gibson, Eric J. Chow, Kevin C. Oeffinger, Gregory T. Armstrong, Louis S. Constine, Bradford S. Hoppe, Yutaka Yasui, Rebecca M. Howell Manuscript writing: All authors Final approval of manuscript: All authors Accountable for all aspects of the work: All authors
Keywords
Subject - Topics
  • Heart--Diseases
  • Cancer

Tools

Relations

In Collection:

Items